Minted: - / 5000

2523 Filorexant
47d29c6b1496b170a057b62e70c52c40493b9ab8e47ce18de8c0c12cb7a38a66

Properties

Background

Green
Bottle

Green
Cap

Light green
Syringe

Red
Bubbles
No
Drops
No
Label
Leaf

Chemistry

Formula
C24H25FN4O2
Carbon
24
Polarity
Neutral

Filorexant (INN, USAN) (code name MK-6096) is an orexin antagonist which is or was under development by Merck for the treatment of insomnia. It is a dual antagonist of the OX₁ and OX₂ receptors. , filorexant has completed phase II clinical trials. It was also investigated as a migraine prophylaxis, but was not found effective, and in major depressive disorder and painful diabetic neuropathy. , filorexant is no longer listed on Merck's online development pipeline.

From Wikipedia, the free encyclopedia. License: CC BY-SA.